EP
Therapeutic Areas
Early Is Good Pipeline
| Drug | Indication | Phase |
|---|---|---|
| BCDx Monitoring | Bladder Cancer — Recurrence Monitoring (Active Surveillance) | Clinical Validation |
| BCDx Detect | Bladder Cancer — Early Detection (Initial Diagnosis) | Clinical Development |
| PCDx | Prostate Cancer — Screening & Risk Stratification | R&D / Early Clinical |
Leadership Team at Early Is Good
TL
Thakshila Liyanage, PhD
Co-Founder & CEO
AA
Asel Ananda, MSc
Co-Founder & CTO
HA
HL Ananda, MBA
Co-Founder & COO
CP
Chamath Palihapitiya
Director (Social Capital)
HK
Hristos Kaimakliotis, MD
Clinical Advisor
CD
Clinton D. Bahler, MD
Clinical Advisor
SG
Saum Ghodoussipour, MD
Clinical Advisor
VW
Vince Wong
Advisor